William L Yankus, a director at $KINS ($KINS), sold 10,253 shares of the company on 12-13-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 10.0% of their shares. Following this trade, they now own 91,834 shares of $KINS stock.
$KINS Insider Trading Activity
$KINS insiders have traded $KINS stock on the open market 11 times in the past 6 months. Of those trades, 9 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $KINS stock by insiders over the last 6 months:
- WILLIAM L YANKUS sold 10,253 shares.
- VICTOR J BRODSKY (Chief Accounting Officer) sold 5,000 shares.
- THOMAS NEWGARDEN has traded it 3 times. They made 3 purchases, buying 15,112 shares and 0 sales.
- TIMOTHY P MCFADDEN purchased 500 shares.
- MINLEI CHEN (Chief Actuary and Senior VP) purchased 1,000 shares.
- CARLA D'ANDRE has traded it 4 times. They made 4 purchases, buying 4,000 shares and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$KINS Hedge Fund Activity
We have seen 31 institutional investors add shares of $KINS stock to their portfolio, and 9 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PHILADELPHIA FINANCIAL MANAGEMENT OF SAN FRANCISCO, LLC added 181,158 shares (+inf%) to their portfolio in Q3 2024
- EVERNEST FINANCIAL ADVISORS, LLC added 129,400 shares (+inf%) to their portfolio in Q3 2024
- RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. added 116,751 shares (+inf%) to their portfolio in Q3 2024
- MARSHALL WACE, LLP added 87,229 shares (+inf%) to their portfolio in Q3 2024
- EAM INVESTORS, LLC added 84,715 shares (+inf%) to their portfolio in Q3 2024
- RENAISSANCE TECHNOLOGIES LLC added 77,200 shares (+20.9%) to their portfolio in Q3 2024
- CRUISER CAPITAL ADVISORS, LLC added 42,960 shares (+inf%) to their portfolio in Q3 2024
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
